multiple myeloma CD38 hedefli monoklonal antikor

Daratumumab Rejimlerinin Çinli MM Hastalarındaki Etkisi

**Real-Dünya Insights into Daratumumab-Based Therapies for Multiple Myeloma in China** In a significant real-world observational study conducted across multiple sites…